Literature DB >> 19162235

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Raj Vuppalanchi1, Aynur Unalp, Mark L Van Natta, Oscar W Cummings, Kumar E Sandrasegaran, Tariq Hameed, James Tonascia, Naga Chalasani.   

Abstract

BACKGROUND & AIMS: Liver biopsy is required to diagnose nonalcoholic steatohepatitis (NASH) in patients with suspected non-alcoholic fatty liver disease (NAFLD); recent studies suggested significant sampling variability. Using percutaneous liver biopsy samples from patients with suspected NAFLD, we examined the relationship between histological yield and length of biopsies, number of cores and number of independent readings.
METHODS: Three cores of liver tissue were collected, by percutaneous liver biopsy, from each of 50 patients suspected to have NAFLD. The diagnostic yield (percent with definite NASH) and other histological findings from 2 independent, blinded examinations of 2 cores and from all 3 cores combined were assessed.
RESULTS: Steatosis, lobular inflammation and fibrosis scores were significantly higher when 3 samples were analyzed, compared with 2. However, between groups, there were no significant differences in hepatocyte ballooning, proportion with an NAFLD activity score > or =4 or proportion with definite NASH (57% vs 61%, P = .3). The length of the biopsy sample correlated with percentage of patients found to have definite NASH (29%, 46%, 56%, and 65% in biopsies measuring <10 mm, 10-14 mm, 15-24 mm, and > or =25 mm, respectively; P < .0001). When biopsy specimens were read twice by the same pathologist, the composite of the 2 independent readings yielded a significantly higher yield for several histological features, compared with the first reading.
CONCLUSIONS: There is a significant relationship between histological yield and sample length and number of independent readings of liver biopsy samples. More studies are needed to optimize the strategy for liver biopsy, to more effectively assess histology in patients with suspected NAFLD.

Entities:  

Mesh:

Year:  2008        PMID: 19162235      PMCID: PMC2770348          DOI: 10.1016/j.cgh.2008.12.015

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

1.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

2.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

3.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

4.  Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.

Authors:  Eduardo Fassio; Estela Alvarez; Nora Domínguez; Graciela Landeira; Cristina Longo
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 5.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Authors:  Stephen A Harrison; Brent A Neuschwander-Tetri
Journal:  Clin Liver Dis       Date:  2004-11       Impact factor: 6.126

6.  Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

Authors:  Terry Gramlich; David E Kleiner; Arthur J McCullough; Christi A Matteoni; Navdeep Boparai; Zobair M Younossi
Journal:  Hum Pathol       Date:  2004-02       Impact factor: 3.466

7.  Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Authors:  Steven P Larson; Steven P Bowers; Nicole A Palekar; John A Ward; Joseph P Pulcini; Stephen A Harrison
Journal:  Clin Gastroenterol Hepatol       Date:  2007-08-16       Impact factor: 11.382

8.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

Authors:  Z M Younossi; T Gramlich; Y C Liu; C Matteoni; M Petrelli; J Goldblum; L Rybicki; A J McCullough
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  46 in total

Review 1.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.

Authors:  Ravi Juluri; Raj Vuppalanchi; John Olson; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; James Tonascia; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

Review 4.  Imaging Modalities in Pediatric NAFLD.

Authors:  Suraj D Serai; Jennifer Panganiban; Manish Dhyani; Andrew J Degnan; Sudha A Anupindi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

5.  Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.

Authors:  Cheng William Hong; Tanya Wolfson; Ethan Z Sy; Alexandra N Schlein; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Gavin Hamilton; Scott B Reeder; Rohit Loomba; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2017-08-26       Impact factor: 4.813

Review 6.  PRO: This Patient Should Have a Liver Biopsy.

Authors:  Akshata Moghe; Matthew Klinge; Naudia Jonassaint
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 7.  Non-invasive diagnosis of advanced fibrosis and cirrhosis.

Authors:  Suraj Sharma; Korosh Khalili; Geoffrey Christopher Nguyen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.

Authors:  Y A Patel; E J Gifford; L M Glass; R McNeil; M J Turner; B Han; D Provenzale; S S Choi; C A Moylan; C M Hunt
Journal:  Aliment Pharmacol Ther       Date:  2017-11-08       Impact factor: 8.171

Review 9.  Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshio Sumida; Atsushi Nakajima; Yoshito Itoh
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Assessment of liver fibrosis using fast strain-encoded MRI driven by inherent cardiac motion.

Authors:  Ahmed A Harouni; Ahmed M Gharib; Nael F Osman; Caryn Morse; Theo Heller; Khaled Z Abd-Elmoniem
Journal:  Magn Reson Med       Date:  2014-07-31       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.